Menu
  • Regulated Press releases
  • Regulated Documents
  • Support
  • Who we are
Skip to main content

Top header menu

  • Access to EMARKET SDIR
  • English
  • Italian
Home
EMARKET STORAGE - Teleborsa

Navigazione principale

  • Regulated Press releases
  • Regulated Documents
  • Support
  • Who we are
Menu

ALL Regulated Press Releases

Home Regulated Press releases
Category
×DIASORIN
Mercato
Modalità di ricerca: Titolo
04/20/2021 - 18:56
DIASORIN
DiaSorin lancia il LIAISON® IQ insieme al primo test per l’identificazione degli anticorpi IgG contro il SARS-CoV-2
04/14/2021 - 10:05
DIASORIN
Communication voting rights amount
04/14/2021 - 10:03
DIASORIN
Comunicazione ammontare complessivo diritti di voto
04/12/2021 - 11:08
DIASORIN
DiaSorin S.p.A. - Weekly report treasury shares buy-back
04/12/2021 - 11:08
DIASORIN
DiaSorin S.p.A. - Informativa settimanale acquisto azioni proprie
04/11/2021 - 19:45
DIASORIN
DiaSorin to acquire Luminex Corporation for USD 37.00 per share or approximately USD 1.8 billion
04/11/2021 - 19:45
DIASORIN
DiaSorin: accordo per acquisire Luminex Corporation per un valore di USD 37,00 per ciascuna azione, per complessivi USD 1,8 Miliardi circa
04/06/2021 - 08:53
DIASORIN
DiaSorin S.p.A.-Start up buy-back plan
04/06/2021 - 08:52
DIASORIN
DiaSorin S.p.A.-Avvio programma acquisto azioni proprie
04/06/2021 - 07:05
DIASORIN
DiaSorin announces its strategic collaboration with Lumos Diagnostics
04/06/2021 - 07:05
DIASORIN
DiaSorin annuncia la collaborazione strategica con Lumos Diagnostics
03/31/2021 - 17:32
DIASORIN
Notice of availability Annual Report and related documentation
03/31/2021 - 17:31
DIASORIN
Avviso disponibilita' Relazione Finanziaria Annuale e documenti correlati
03/29/2021 - 07:02
DIASORIN
DiaSorin has obtained FDA Emergency Use Authorization for its LIAISON® SARS-CoV-2 Ag for COVID-19 testing in the U.S.
03/29/2021 - 07:02
DIASORIN
DiaSorin: il test dell’antigene LIAISON® SARS-CoV-2 Ag per la diagnosi del COVID-19 ha ricevuto l’approvazione ad uso di emergenza negli Stati Uniti
03/19/2021 - 17:37
DIASORIN
DiaSorin S.p.A. - Notice of Shareholders' Meeting April 22, 2021
03/19/2021 - 17:36
DIASORIN
DiaSorin S.p.A. - Assemblea degli Azionisti 22 aprile 2021 - Avviso di convocazione
03/11/2021 - 16:47
DIASORIN
DiaSorin S.p.A. - Dividend coupon date correction
03/11/2021 - 16:36
DIASORIN
DiaSorin S.p.A. - Rettifica data stacco dividendo
03/11/2021 - 15:37
DIASORIN
DiaSorin – Revenues, Profitability and Cash Flow Generation hit record highs in 2020
03/11/2021 - 15:36
DIASORIN
DiaSorin – Ricavi, Redditività e Generazione di Cassa Record nel 2020
01/27/2021 - 18:50
DIASORIN
DiaSorin S.p.A. - 2021 Annual Calendar of Corporate Events
01/27/2021 - 18:48
DIASORIN
DiaSorin S.p.A. - Calendario Annuale Eventi Societari 2021
01/11/2021 - 18:42
DIASORIN
DiaSorin launches with CE mark the LIAISON SARS-CoV-2 TrimericS IgG test

Pagination

  • First page « First
  • Previous page ‹ Precedente
  • …
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • Current page 14
  • Page 15
  • Page 16
  • Page 17
  • Page 18
  • …
  • Next page Seguente ›
  • Last page Last »

Footer menu

  • Disclaimer
  • Privacy
  • Cookies
  • Emergency assistance

Teleborsa - Logo

©Copyright 2022 Teleborsa S.r.l. No material on this site may be published, distributed, sold or reproduced in any form, whether printed or written, without the authorization of Teleborsa S.r.l.

Close menu